The notices it replaced
- Reissues: RFA-OD-21-007 INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Exploratory/Developmental Research Grant Award (R21 Clinical Trial Not Allowed)
Who won it before
10 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,224,280 in first-year total cost, median $246,375.
Most frequent study sections
- Special Emphasis Panel[ZRG1 IVBH-A (56)]5
- Special Emphasis Panel[ZRG1 VH-N (90)]3
- Special Emphasis Panel[ZRG1 IVBH-B (56)]2
Most frequent institutions
- UNIVERSITY OF COLORADO DENVER2
- ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI1
- LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER1
- MASSACHUSETTS GENERAL HOSPITAL1
- RESEARCH INST NATIONWIDE CHILDREN'S HOSP1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Characterizing DNA Methylation Dynamics in Trisomy 21-Associated Hematopoiesis and Leukemia1R21CA301237-01 · under RFA-OD-21-007 | MA, SAIWAGENBLAST, ELVIN | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $462,454 | ZRG1 |
| 2025 | CRISPR interference to identify HSA21 genes reducing neurogenesis1R21HD118402-01 · under RFA-OD-21-007 | MUNSHI, NIKHIL VILASROTHERMEL, BEVERLY A | UT SOUTHWESTERN MEDICAL CENTER, TX | $451,000 | ZRG1 |
| 2025 | Developing and implementing community based participatory health research with young adults with Down syndrome1R21HD118449-01 · under RFA-OD-21-007 | CHANNELL, MARIE MOORE | UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN, IL | $446,096 | ZRG1 |
| 2025 | Defining the association between trisomy 21 and placentation defects1R21HD118444-01 · under RFA-OD-21-007 | BRUMBAUGH, JUSTIN | UNIVERSITY OF COLORADO, CO | $430,375 | ZRG1 |
| 2025 | Single cell analysis of dysregulated inducible DNA amplifications of immune response genes in Down syndrome1R21AI190900-01 · under RFA-OD-21-007 | SULLIVAN, KELLY D. | UNIVERSITY OF COLORADO DENVER, CO | $234,000 | ZRG1 |
| 2024 | Imaging of Mitochondial Complex I function in Down Syndrome1R21AG086927-01 · under RFA-OD-21-007 | PRICE, JULIE CROSAS, HERMINIA DIANA | MASSACHUSETTS GENERAL HOSPITAL, MA | $250,500 | ZRG1 |
| 2024 | Characterizing Language and Motor Development of Racially/Ethnically Diverse Infants and Toddlers with Down Syndrome1R21DC021818-01 · under RFA-OD-21-007 | FLORES, MEGANVANEGAS, SANDRA | UNIVERSITY OF TEXAS AT AUSTIN, TX | $240,355 | ZRG1 |
| 2022 | type I interferon regulates angiogenesis in Down Syndrome1R21HL165411-01 · under RFA-OD-21-007 | AL-ALAM, DENISEDANOPOULOS, SOULA ATHANASIA | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER, CA | $242,250 | ZRG1 |
| 2022 | Dissecting SARS-CoV-2 infection in Down syndrome with congenital heart defects using patient-specific iPSCs1R21HL165406-01 · under RFA-OD-21-007 | ZHAO, MINGTAO | RESEARCH INST NATIONWIDE CHILDREN'S HOSP, OH | $234,000 | ZRG1 |
| 2022 | Abnormal HIF signaling in Down syndrome-related pulmonary hypertension1R21HL165364-01 · under RFA-OD-21-007 | GALAMBOS, CSABA | UNIVERSITY OF COLORADO DENVER, CO | $233,250 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.